GlassScriptPhysician profile
Brian Keith Williams
NPI 1265641013
$1,000.92
in general payments reported to CMS, 2019-2025
15 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.14 · 2021: $14.94 · 2022: $59.72 · 2023: $198 · 2024: $237 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $378.89 | 2021-2025 | Ilumya |
| Convatec INC. | $138.37 | 2025 | |
| Relievant Medsystems, INC. | $94.86 | 2023 | Intracept |
| Verona Pharma, INC. | $79.83 | 2025 | Ohtuvayre |
| Atricure, INC. | $49.20 | 2023 | |
| Straumann USA LLC | $46.89 | 2025 | |
| Dermavant Sciences, INC. | $44.37 | 2024 | Vtama |
| Organon LLC | $42.37 | 2025 | Vtama |
| Janssen Biotech, INC. | $38.65 | 2022-2023 | Stelara, Remicade, Simponi Aria |
| Kestra Medical Technology Services, INC. | $20.01 | 2024 | Assure Wcd |
| Pacira Pharmaceuticals Incorporated | $17.65 | 2024 | Exparel |
| Harrow Eye, LLC | $16.86 | 2025 | Vevye |
| Journey Medical Corporation | $14.78 | 2025 | |
| Hollister Incorporated | $13.05 | 2023 | Vapro Pocket, Onli, Infyna Chic |
| Prugen, INC. Pharmaceuticals | $5.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.